REPROCELL
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clini... cal testing services that is required by hematopoietic stem cell transplantation and organ transplantation. On February 10, 2014, it established a Kanagawa-based wholly owned subsidiary. On June 30, 2014, it acquired 85.2% interests in Reinnervate Limited, a UK-based company. On July 1, 2014, it fully acquired Reinnervate Limited. In July, 2014, it acquired BioServe Biotechnologies, Ltd. On September 2, 2014, it completed the acquisition of BioServe Biotechnologies, Ltd.
REPROCELL
Industry:
Biotechnology Health Care Manufacturing Test And Measurement
Founded:
2003-01-01
Address:
Yokohama, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.reprocell.com
Total Employee:
51+
Status:
Active
Contact:
(814) 547-5388
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-04-25 | BioServe Biotechnologies (India) | BioServe Biotechnologies (India) acquired by ReproCELL | N/A |
| 2015-11-24 | Biopta | Biopta acquired by ReproCELL | N/A |
| 2014-08-05 | ReInnervate | ReInnervate acquired by ReproCELL | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-25 | Symic Biomedical | ReproCELL investment in Series C - Symic Biomedical | 11 M USD |
| 2016-12-05 | Kringle Pharma | ReproCELL investment in Venture Round - Kringle Pharma | 610 M JPY |
Official Site Inspections
http://www.reprocell.com Semrush global rank: 1.46 M Semrush visits lastest month: 18.72 K
- Host name: 109.108.148.102.srvlist.ukfast.net
- IP address: 109.108.148.102
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "ReproCELL"
REPROCELL Global
Discover REPROCELL's pioneering 3D skin tissue engineering, enhancing drug development and skincare research with accurate and robust human skin models. Plasma or Serum? – You …See details»
About REPROCELL
Over the last decade, REPROCELL has evolved its global infrastructure, corporate organization, and strategy. By leveraging our knowledge base of stem cell technologies, REPROCELL has …See details»
Our services and products for stem cells and drug discovery
Our services and products for stem cells and drug discovery enable scientists worldwide to translate their research into clinical therapies. Established in 2003 by preeminent Japanese …See details»
Drug Discovery & Clinical Services - REPROCELL
Our services help stem cell and drug discovery scientists around the world advance their preclinical and clinical research. We have a complete portfolio of services for the reprogramming and differentiation of high-quality induced …See details»
ReproCELL - Crunchbase Company Profile & Funding
ReproCELL is a clinical testing services company that develops regenerative medicine products. View contacts for ReproCELL to access new leads and connect with decision-makers. ReproCELL Incorporated is primarily engaged …See details»
REPROCELL - LinkedIn
With our deep knowledge of stem cell biology, bioengineered (3D) tissue models (Alvetex) cell differentiation, and pharmacology, REPROCELL is a recognized leader in cutting-edge tools …See details»
Improving human health through biomedical innovation and
REPROCELL has one of the worldʼs largest commercial biorepositories of human tissue samples, including over 600,000 samples of frozen tissue, FFPE tissue blocks, whole blood, serum, …See details»
ReproCELL Incorporated | J-Startup
REPROCELL, founded in 2003, has extensive and accumulated capabilities in iPS cells. As a pioneer with a global outreach in USA, UK, and India, we continue to drive science and …See details»
Reprocell, USA - MSCRF
Sep 25, 2024 · Reprocell's neuroscience platform enable scientists to use iPSC-derived neurons in neurotoxicity, drug discovery and efficacy screening. They strive to develop improved …See details»
REPROCELL - YouTube
REPROCELL provide an integrated workflow with stem cells and discovery technologies for drug development and cutting-edge Regenerative Medicine. As a global technology partner, …See details»
ReproCELL - Products, Competitors, Financials, Employees, …
REPROCELL is a company focused on supporting stem cell research and preclinical drug development within the biotechnology sector. Use the CB Insights Platform to explore …See details»
Reprocell and JTB commence offering - JTBコーポレートサイト
Jul 11, 2024 · Reprocell Inc. (Headquarters: Kanagawa, hereinafter "Reprocell") and JTB Corp. (Headquarters: Tokyo, hereinafter "JTB") announce that JTB becomes the general agent for …See details»
Contact REPROCELL
Message our expert scientists worldwide by our online form, or contact any of our offices worldwide by email, phone or postal service.See details»
REPROCELL Launches New Global Website
Jan 15, 2018 · Headquartered in Yokohama (Japan), REPROCELL is an integrated research and medical company. Serving the global market, the REPROCELL Discovery business unit is …See details»
FREQUENTLY ASKED QUESTIONS - REPROCELL
REPROCELL provides unrivaled access to clinical-grade IRB-approved human samples. We’ve developed our large bank of tissue samples for 17 years and continue to develop methods to …See details»
ReproCELL - Funding, Financials, Valuation & Investors - Crunchbase
Jun 5, 2024 · ReproCELL has acquired 3 organizations. Their most recent acquisition was BioServe Biotechnologies (India) on Apr 25, 2018. Which types of acquisition does this …See details»
Celebrating the 20th Anniversary of REPROCELL: A letter from our …
Feb 26, 2023 · Since 2003, our research and development activities using ES cells had contributed significantly to the discovery of iPS cells and REPROCELL was well positioned to …See details»
ReproCELL | Life Sciences PA
Our expert scientists are on-hand 24/7 to create data in fresh human tissues that will add commercial value and de-risk drug development programmes by predicting the safety, …See details»
The ultimate guide to REPROCELL’s stem cell research services
Aug 16, 2021 · At REPROCELL, we provide a broad range of stem cell services, so that you can achieve high-quality data with the least amount of hassle. Watch our explainer video below to …See details»